Literature DB >> 2479578

Insertion of short hepatitis virus A amino acid sequences into poliovirus antigenic determinants results in viable progeny.

E D Sverdlov1, S A Tsarev, S V Markova, V M Rostapshov, T L Azhikina, I P Chernov, A E Gorbalenya, M S Kolesnikova, L I Romanova, N L Teterina.   

Abstract

In an infectious poliovirus cDNA construct, the determinant encoding antigenic epitope N-Ag1 (in a loop located between two beta-strands in poly-peptide VP1) was altered by site-directed mutagenesis, to be partially similar with the determinants for presumptive epitopes in polypeptides VP1 or VP3 of hepatitis A virus (HAV). The modified constructs proved to be infectious. However, another construct, in which the same locus encoded a 'nonsense' and a relatively hydrophobic amino acid sequence, exhibited no infectivity. These data showed the feasibility of the insertion of foreign sequences in a specific antigenically active locus of the poliovirus icosahedron, and suggest some limitations with respect to the sequences to be 'transplanted'.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2479578     DOI: 10.1016/0014-5793(89)81570-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  4 in total

1.  Infectious enveloped RNA virus antigenic chimeras.

Authors:  S D London; A L Schmaljohn; J M Dalrymple; C M Rice
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Unique region of the minor capsid protein of human parvovirus B19 is exposed on the virion surface.

Authors:  S J Rosenfeld; K Yoshimoto; S Kajigaya; S Anderson; N S Young; A Field; P Warrener; G Bansal; M S Collett
Journal:  J Clin Invest       Date:  1992-06       Impact factor: 14.808

3.  Viable polioviruses that encode 2A proteins with fluorescent protein tags.

Authors:  Natalya L Teterina; Eric A Levenson; Ellie Ehrenfeld
Journal:  J Virol       Date:  2009-11-25       Impact factor: 5.103

4.  Structural basis of mercury- and zinc-conjugated complexes as SARS-CoV 3C-like protease inhibitors.

Authors:  Cheng-Chung Lee; Chih-Jung Kuo; Min-Feng Hsu; Po-Huang Liang; Jim-Min Fang; Jiun-Jie Shie; Andrew H-J Wang
Journal:  FEBS Lett       Date:  2007-11-05       Impact factor: 4.124

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.